Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

Journal of Surgical Oncology

Volumn 96, Issue 6, 2007, Pages 474-480

  Segara, Davendra ^a   Krop, Ian E ^b   Garber, Judy E ^b   Winer, Eric ^b   Harris, Lyndsay ^b   Bellon, Jennifer R ^a   Birdwell, Robyn ^a   Lester, Susan ^a   Lipsitz, Stuart ^a   Iglehart, J Dirk ^a   Golshan, Mehra ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Breast MRI; Neoadjuvant therapy

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GADOLINIUM PENTETATE; NAVELBINE; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY;

EID: 35748958431     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20856     Document Type: Article

References (32)

1. Fisher B, Anderson S: Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg 1994;18:63-69.
2. Schwartz GF, Veronesi U, Clough KB, et al.: Consensus conference on breast conservation. J Am Coll Surg 2006;203:198-207.
3. Bonadonna G, Veronesi U, Brambilla C, et al.: Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82:1539-1545.
4. van der Hage JA, van de Velde CJ, Julien JP, et al.: Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001;19:4224-4237.
5. Bonadonna G, Valagussa P, Brambilla C, et al.: Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998;16:93-100.
6. Wolmark N, Wang J, Mamounas E, et al.: Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001; 96-102.
7. Mankoff DA, Dunnwald LK, Gralow JR, et al.: Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 2003;44:1806-1814.
8. Fornage BD, Toubas O, Morel M: Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer 1987;60:765-771.
9. Madjar H, Ladner HA, Sauerbrei W, et al.: Preoperative staging of breast cancer by palpation, mammography and high-resolution ultrasound. Ultrasound Obstet Gynecol 1993;3:185-190.
10. Hieken TJ, Harrison J, Herreros J, et al.: Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg 2001;182:351-354.
11. Bosch AM, Kessels AG, Beets GL, et al.: Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: A prospective study on 105 invasive tumours. Eur J Radiol 2003;48:285-292.
12. Golshan M, Fung BB, Wiley E, et al.: Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast 2004;13:265-271.
13. Pritt B, Ashikaga T, Oppenheimer RG, et al.: Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements. Mod Pathol 2004;17:905-910.
14. Heywang SH, Hahn D, Schmidt H, et al.: MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986;10:199-204.
15. Harms SE, Flamig DP, Hesley KL, et al.: MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation. Radiology 1993;187:493-501.
16. Heywang SH, Fenzl G, Hahn D, et al.: MR imaging of the breast: Comparison with mammography and ultrasound. J Comput Assist Tomogr 1986;10:615-620.
17. Kuhl CK, Schmutzler RK, Leutner CC, et al.: Breast MR imaging Screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results. Radiology 2000;215:267-279.
18. Kriege M, Brekelmans CT, Boetes C, et al.: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-437.
19. Ogston KN, Miller ID, Payne S, et al.: A new histological grading system to assess response of breast cancers to primary chemotherapy: Prognostic significance and survival. Breast 2003;12:320-327.
20. Therasse P, Arbuck SG, Eisenhauer EA, et al.: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
21. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
22. Chen AM, Meric-Bernstam F, Hunt KK, et al.: Breast conservation after neoadjuvant chemotherapy: The MD Anderson cancer center experience. J Clin Oncol 2004;22:2303-2312.
23. Beresford M, Padhani AR, Goh V, et al.: Imaging breast cancer response during neoadjuvant systemic therapy. Expert Rev Anticancer Ther 2005;5:893-905.
24. Nakamura T, Fukutomi T, Tsuda H, et al.: Changes in findings of mammography, ultrasonography and contrast-enhanced computed tomography of three histological complete responders with primary breast cancer before and after neoadjuvant chemotherapy: Case reports. Jpn J Clin Oncol 2000;30:453-457.
25. Chagpar AB, Middleton LP, Sahin AA, et al.: Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 2006;243:257-264.
26. Peintinger F, Kuerer HM, Anderson K, et al.: Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 2006;13:1443-1449.
27. Gilles R, Guinebretiere JM, Toussaint C, et al.: Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633-638.
28. Londero V, Bazzocchi M, Del Frate C, et al.: Locally advanced breast cancer: Comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004;14:1371-1379.
29. Schott AF, Roubidoux MA, Helvie MA, et al.: Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005;92:231-238.
30. Partridge SC, Gibbs JE, Lu Y, et al.: Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002;179:1193-1199.
31. Rosen EL, Blackwell KL, Baker JA, et al.: Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 2003;181:1275-1282.
32. Altman DG, Bland JM: Measurement in medicine: The analysis of method comparison studies. Statistician 1983;32:307-317.